Dentistry Dentistry

Bioactive Skin Regeneration

Support for Modern Dentistry

THERAVEX® supports oral tissue recovery by helping optimise the healing microenvironment after dental procedures and in selected oral conditions —designed for implantologists, oral surgeons, periodontists, and general dental practitioners who expect more from their post-procedure protocols.

Clinical Challenge

Oral tissues are constantly exposed to bacterial load, inflammation, mechanical stress, and post-procedure irritation. In implantology, oral surgery, periodontology, and mucositis management, recovery quality can influence patient comfort, tissue stability, and long-term clinical confidence.

Recommended

Products

Theravex Tissue Care Vial

(where protocol-indicated)

How Theravex Helps

Theravex supports oral tissue recovery by helping optimise the healing microenvironment after dental procedures and in selected oral conditions —designed for implantologists, oral surgeons, periodontists, and general dental practitioners who expect more from their post-procedure protocols.

Applications

Oral surgery recovery

Dry socket support

Periodontal tissue recovery

Peri-implant tissue support

Bone grafting support environment

Post-procedure comfort

Oral mucositis support

Key Benefit Pillars

One bioactive adjunct across hard- and soft-tissue procedures—supporting early oral wound healing, postoperative comfort, graft integration conditions, and implant stability within established dental protocols.

Evidence Highlight

  • In a randomized, double-blind clinical trial of 81 patients, BBL/THERAVEX mouthwash was used twice daily for seven days after oral surgery and compared with 0.12% chlorhexidine.
  •  Pain improved in both groups, but the BBL group showed a statistically significant advantage beginning on Day 4.
  •  Early Healing Index scores at Day 7 were significantly higher with BBL; no adverse effects were reported in the study, while tooth staining occurred in the chlorhexidine group.
  • In a randomized, double-blind implant study of 33 participants and 264 implants, THERAVEX-treated implants showed lower pain by Day 7, improved stability by Day 30, and a more favourable peri-implant bone-area response on CBCT by Day 60. These findings support an adjunctive healing claim, not a guarantee of osseointegration or bone regeneration.
Before
After

Request

Dental Medical Visit